Manufacturer
Eli Lilly and Company NDC Codes
Finished products listed with the FDA under labeler names that contain “Eli Lilly”.
Products
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Mounjaro KwikPentirzepatide | Tirzepatide 20.8 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3422 |
| Mounjaro KwikPentirzepatide | Tirzepatide 16.7 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3433 |
| Mounjaro KwikPentirzepatide | Tirzepatide 12.5 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3444 |
| Mounjaro KwikPentirzepatide | Tirzepatide 8.33 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3455 |
| Mounjaro KwikPentirzepatide | Tirzepatide 4.17 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3466 |
| Olumiantbaricitinib | Baricitinib 2 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4182 |
| Olumiantbaricitinib | Baricitinib 4 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4479 |
| Olumiantbaricitinib | Baricitinib 1 mg/1 | Tablet, Film coatedOral | Eli Lilly and Company | 0002-4732 |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-1442 |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-3116 |
| Omvohmirikizumab-mrkz | Mirikizumab 20 mg/mL | Injection, SolutionIntravenous | Eli Lilly and Company | 0002-7575 |
| Omvohmirikizumab-mrkz | — | KitSubcutaneous, Subcutaneous | Eli Lilly and Company | 0002-7717 |
| Omvohmirikizumab-mrkz | — | KitSubcutaneous, Subcutaneous | Eli Lilly and Company | 0002-7722 |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8011 |
| Omvohmirikizumab-mrkz | Mirikizumab 100 mg/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-8870 |
| ONSWIK KwikPeninsulin efsitora alfa-gobe | Insulin efsitora alfa 500 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-5137 |
| ONSWIK KwikPeninsulin efsitora alfa-gobe | Insulin efsitora alfa 1000 [iU]/mL | Injection, SolutionSubcutaneous | Eli Lilly and Company | 0002-5240 |
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-2980 |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | CapsuleOral | Eli Lilly and Company | 0002-3977 |
| Retevmoselpercatinib | Selpercatinib 40 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-5340 |
| Retevmoselpercatinib | Selpercatinib 160 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-5562 |
| Retevmoselpercatinib | Selpercatinib 80 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6082 |
| Retevmoselpercatinib | Selpercatinib 120 mg/1 | Tablet, CoatedOral | Eli Lilly and Company | 0002-6120 |
| Reyvowlasmiditan | Lasmiditan 50 mg/1 | TabletOral | Eli Lilly and Company | 0002-4312 |
| Reyvowlasmiditan | Lasmiditan 100 mg/1 | TabletOral | Eli Lilly and Company | 0002-4491 |